Michael N Passarelli1, Polly A Newcomb, Karen W Makar, Andrea N Burnett-Hartman, Amanda I Phipps, Sean P David, Li Hsu, Tabitha A Harrison, Carolyn M Hutter, David J Duggan, Emily White, Andrew T Chan, Ulrike Peters. 1. From the 1Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA; 2Department of Epidemiology, University of Washington School of Public Health, Seattle, WA; 3Division of General Medical Disciplines, Stanford University School of Medicine, Stanford, CA; 4SRI International, Menlo Park, CA; 5Department of Biostatistics, University of Washington School of Public Health, Seattle, WA; 6Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ; 7Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and 8Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Abstract
OBJECTIVE: Sex steroid hormones play a role in colorectal cancer (CRC) development, but little is known about their influence on tumor progression and metastasis. Because catechol-O-methyltransferase (COMT; 22q11.21) activity is an important component of estrogen-mediated carcinogenesis, we hypothesized that germline variation in COMT may be associated with CRC survival. METHODS: We identified 10 single nucleotide polymorphisms that tagged variation across two isoforms of COMT in 2,458 women with CRC from the Nurses' Health Study, Postmenopausal Hormones Supplementary Study to the Colon Cancer Family Registry, VITamins And Lifestyle Study, and Women's Health Initiative. All four studies participated in the Genetics and Epidemiology of Colorectal Cancer Consortium. RESULTS: During a median follow-up of 7 years across all studies, there were 799 deaths, including 566 deaths from CRC. Based on multiple comparisons, no associations between single nucleotide polymorphisms and CRC-specific or overall survival reached statistical significance, including the well-characterized Val108/158Met polymorphism (rs4680; CRC-specific survival: hazard ratio per minor allele, 1.04; 95% CI, 0.92-1.17; overall survival: hazard ratio per minor allele, 1.01; 95% CI, 0.90-1.14). CONCLUSIONS: In this large study of women with CRC, we find no evidence that common inherited variation in COMT is associated with survival time after diagnosis.
OBJECTIVE: Sex steroid hormones play a role in colorectal cancer (CRC) development, but little is known about their influence on tumor progression and metastasis. Because catechol-O-methyltransferase (COMT; 22q11.21) activity is an important component of estrogen-mediated carcinogenesis, we hypothesized that germline variation in COMT may be associated with CRC survival. METHODS: We identified 10 single nucleotide polymorphisms that tagged variation across two isoforms of COMT in 2,458 women with CRC from the Nurses' Health Study, Postmenopausal Hormones Supplementary Study to the Colon Cancer Family Registry, VITamins And Lifestyle Study, and Women's Health Initiative. All four studies participated in the Genetics and Epidemiology of Colorectal Cancer Consortium. RESULTS: During a median follow-up of 7 years across all studies, there were 799 deaths, including 566 deaths from CRC. Based on multiple comparisons, no associations between single nucleotide polymorphisms and CRC-specific or overall survival reached statistical significance, including the well-characterized Val108/158Met polymorphism (rs4680; CRC-specific survival: hazard ratio per minor allele, 1.04; 95% CI, 0.92-1.17; overall survival: hazard ratio per minor allele, 1.01; 95% CI, 0.90-1.14). CONCLUSIONS: In this large study of women with CRC, we find no evidence that common inherited variation in COMT is associated with survival time after diagnosis.
Authors: Ulrike Peters; Carolyn M Hutter; Li Hsu; Fredrick R Schumacher; David V Conti; Christopher S Carlson; Christopher K Edlund; Robert W Haile; Steven Gallinger; Brent W Zanke; Mathieu Lemire; Jagadish Rangrej; Raakhee Vijayaraghavan; Andrew T Chan; Aditi Hazra; David J Hunter; Jing Ma; Charles S Fuchs; Edward L Giovannucci; Peter Kraft; Yan Liu; Lin Chen; Shuo Jiao; Karen W Makar; Darin Taverna; Stephen B Gruber; Gad Rennert; Victor Moreno; Cornelia M Ulrich; Michael O Woods; Roger C Green; Patrick S Parfrey; Ross L Prentice; Charles Kooperberg; Rebecca D Jackson; Andrea Z Lacroix; Bette J Caan; Richard B Hayes; Sonja I Berndt; Stephen J Chanock; Robert E Schoen; Jenny Chang-Claude; Michael Hoffmeister; Hermann Brenner; Bernd Frank; Stéphane Bézieau; Sébastien Küry; Martha L Slattery; John L Hopper; Mark A Jenkins; Loic Le Marchand; Noralane M Lindor; Polly A Newcomb; Daniela Seminara; Thomas J Hudson; David J Duggan; John D Potter; Graham Casey Journal: Hum Genet Date: 2011-07-15 Impact factor: 4.132
Authors: Michael N Passarelli; Amanda I Phipps; John D Potter; Karen W Makar; Anna E Coghill; Karen J Wernli; Emily White; Andrew T Chan; Carolyn M Hutter; Ulrike Peters; Polly A Newcomb Journal: Cancer Res Date: 2012-11-13 Impact factor: 12.701
Authors: Michael S Simon; Rowan T Chlebowski; Jean Wactawski-Wende; Karen C Johnson; Andrew Muskovitz; Ikuko Kato; Alicia Young; F Allan Hubbell; Ross L Prentice Journal: J Clin Oncol Date: 2012-09-24 Impact factor: 44.544
Authors: Ulrike Peters; Shuo Jiao; Fredrick R Schumacher; Carolyn M Hutter; Aaron K Aragaki; John A Baron; Sonja I Berndt; Stéphane Bézieau; Hermann Brenner; Katja Butterbach; Bette J Caan; Peter T Campbell; Christopher S Carlson; Graham Casey; Andrew T Chan; Jenny Chang-Claude; Stephen J Chanock; Lin S Chen; Gerhard A Coetzee; Simon G Coetzee; David V Conti; Keith R Curtis; David Duggan; Todd Edwards; Charles S Fuchs; Steven Gallinger; Edward L Giovannucci; Stephanie M Gogarten; Stephen B Gruber; Robert W Haile; Tabitha A Harrison; Richard B Hayes; Brian E Henderson; Michael Hoffmeister; John L Hopper; Thomas J Hudson; David J Hunter; Rebecca D Jackson; Sun Ha Jee; Mark A Jenkins; Wei-Hua Jia; Laurence N Kolonel; Charles Kooperberg; Sébastien Küry; Andrea Z Lacroix; Cathy C Laurie; Cecelia A Laurie; Loic Le Marchand; Mathieu Lemire; David Levine; Noralane M Lindor; Yan Liu; Jing Ma; Karen W Makar; Keitaro Matsuo; Polly A Newcomb; John D Potter; Ross L Prentice; Conghui Qu; Thomas Rohan; Stephanie A Rosse; Robert E Schoen; Daniela Seminara; Martha Shrubsole; Xiao-Ou Shu; Martha L Slattery; Darin Taverna; Stephen N Thibodeau; Cornelia M Ulrich; Emily White; Yongbing Xiang; Brent W Zanke; Yi-Xin Zeng; Ben Zhang; Wei Zheng; Li Hsu Journal: Gastroenterology Date: 2012-12-22 Impact factor: 22.682
Authors: Jennifer H Lin; JoAnn E Manson; Peter Kraft; Barbara B Cochrane; Marc J Gunter; Rowan T Chlebowski; Shumin M Zhang Journal: BMC Med Genet Date: 2011-05-31 Impact factor: 2.103
Authors: Kathryn T Hall; Julie E Buring; Kenneth J Mukamal; M Vinayaga Moorthy; Peter M Wayne; Ted J Kaptchuk; Elisabeth M Battinelli; Paul M Ridker; Howard D Sesso; Stephanie J Weinstein; Demetrius Albanes; Nancy R Cook; Daniel I Chasman Journal: J Natl Cancer Inst Date: 2019-07-01 Impact factor: 13.506